Skip to main content
Eric Kramer, MD, Neurology, Atlantis, FL

EricDKramerMD

Neurology Atlantis, FL

Physician

Dr. Kramer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Kramer's full profile

Already have an account?

  • Office

    140 Jfk Dr
    Atlantis, FL 33462
    Phone+1 561-968-6767
    Fax+1 561-641-0814

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Neurology, 1989 - 1990
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Neurology, 1985 - 1988
  • Cooper Medical School of Rowan University/Cooper University Hospital
    Cooper Medical School of Rowan University/Cooper University HospitalInternship, Internal Medicine, 1984 - 1985
  • Lewis Katz School of Medicine at Temple University
    Lewis Katz School of Medicine at Temple UniversityClass of 1984

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2002 - 2026
  • PA State Medical License
    PA State Medical License 1985 - 2024
  • NJ State Medical License
    NJ State Medical License 1990 - 2003
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012-2013
  • Super Doctor SuperDoctors.com

Publications & Presentations

PubMed

Press Mentions

  • JEM Research Institute Seeks Participants for Sunovion’s Investigational Treatment for Parkinson’s Disease Psychosis Clinical Trial
    JEM Research Institute Seeks Participants for Sunovion’s Investigational Treatment for Parkinson’s Disease Psychosis Clinical TrialOctober 2nd, 2019
  • SEP361-203 Study Evaluating an Investigational Medication in People with Parkinson's Disease Experiencing Hallucinations and Delusions
    SEP361-203 Study Evaluating an Investigational Medication in People with Parkinson's Disease Experiencing Hallucinations and DelusionsOctober 1st, 2019